Answers are grounded in this paper and cite their sources.
Joubert Syndrome (JBTS) is a ciliopathy and disease-causing variants in CEP290 are the leading cause of JBTS presenting with cerebello-retinal-renal phenotypes. We investigated a Brazilian child with JBTS and compound heterozygous variants in CEP290. Using patient derived fibroblasts, we characterised the c.6271-8T>G intron 46 splice site allele using RT-PCR, confirming it led to a 7 bp intronic inclusion leading to a frameshift and downstream nonsense variant p.(Asn2091Leufs*12). Patient fibroblasts displayed elongated and tortuous primary cilia and a decreased primary ciliation rate. We reviewed other Brazilian cohorts where the CEP290 c.6271-8T>G allele had been reported in homozygosity or in compound heterozygosity with a second pathogenic variant. Phenotypes associated with this allele included Leber congenital amaurosis, nephronophthisis and JBTS. Finally, we used antisense oligonucleotide (ASO) mediated exon skipping of exon 46, an 87 base pair exon which if skipped is not predicted to disrupt reading frame or CEP290 protein structure, in patient fibroblasts to rescue ciliary phenotypes and CEP290 protein expression at ciliary the transition zone. These findings confirm that the CEP290 c.6271-8T>G is a pathogenic splice-site variant and pathogenic alleles within or disrupting exon 46 splicing including c.6271-8T>G are amenable to targeted ASO mediated exon skipping as a future therapeutic strategy.
No takes yet. Share an insight, caveat, or question.
Dewhurst et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: